- Home
- LIQT vs ASBP Comparison
LIQT vs ASBP Comparison
Compare LIQT & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIQT | ASBP |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 7.6M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | LIQT | ASBP |
|---|---|---|
| Price | $1.40 | $1.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.30 | N/A |
| AVG Volume (30 Days) | 8.6K | ★ 165.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.32 | N/A |
| Revenue Next Year | $71.69 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.34 | $0.05 |
| 52 Week High | $3.35 | $2.45 |
Technical Indicators
Market Signals| Indicator | LIQT | ASBP |
|---|---|---|
| Relative Strength Index (RSI) | 39.90 | 39.48 |
| Support Level | N/A | $0.31 |
| Resistance Level | $2.00 | $1.61 |
| Average True Range (ATR) | 0.21 | 0.13 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 10.00 | 0.91 |
Price Performance
Historical ComparisonAbout LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.
About ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.